AQP4+ NMOSD

Clinical trials for AQP4+ NMOSD explained in plain language.

Never miss a new study

Get alerted when new AQP4+ NMOSD trials appear

Sign up with your email to follow new studies for AQP4+ NMOSD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Experimental CAR t treatment targets root cause of rare nerve disease

Disease control Not yet recruiting

This early-phase trial tests whether a new CAR T cell therapy called CC-97540 is safe for people with a rare autoimmune disease called neuromyelitis optica (NMOSD). The study will enroll 5 adults who are stable on current treatments. Researchers will check for side effects and wh…

Matched conditions: AQP4+ NMOSD

Phase: PHASE1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control

Last updated Jul 19, 2026 00:00 UTC

AQP4+ NMOSD

Get alerted when new AQP4+ NMOSD trials appear

Experimental CAR t treatment targets root cause of rare nerve disease